Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies
Stanford University · Cardiovascular Institute of the South · +4 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
723
total citations
- FWCI
- 25.58
- Percentile
- 100%
- References
- 69
Citations per year
Authors
5- ASAndrew S. Lee
Stanford University, Cardiovascular Institute of the South
- CTChad Tang
The University of Texas MD Anderson Cancer Center, Stanford University
- MSMahendra S. RaoCorresponding
Center for Neuroscience and Regenerative Medicine, National Institutes of Health
- ILIrving L. Weissman
Stanford University
- JCJoseph C. Wu
Stanford Medicine, Cardiovascular Institute of the South, Stanford University
Topics & keywords
Topics
Keywords
- Induced pluripotent stem cell
- Clinical trial
- Stem cell
- Human Induced Pluripotent Stem Cells
- Medicine
- Neuroscience
- Spinal cord injury
- Biology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.